Back to companies

Puretech Health Plc (Puretech) formerly PureTech Ventures LLC, is a biotherapeutics company that discovers, develops, and commercializes drugs to treat lung dysfunction, immuno-oncology, lymphatic, neurological, and neuropsychological disorders. The company is investigating pipeline programs such as LYT-100 (deupirfenidone), targeting inflammation and fibrosis, lymphedema, and SARS-CoV-2 respiratory problems; LYT-200, a human monoclonal antibody for the treatment of pancreatic ductal adenocarcinoma (PDAC), colorectal cancer (CRC) and cholangiocarcinoma (CCA); and LYT-210, a gamma delta-1 T cell receptor against solid tumors. It is also evaluating LYT-300, oral allopregnanolone for neurological indications. Puretech works in collaboration with pharmaceutical and biotechnology companies to develop its products. Puretech is headquartered in Boston, Massachusetts, the US.

Headquarters United States of America

Address 501 Boylston St Ste 6102, Boston, Massachusetts, 02116-3769


Telephone 1 617 4822333

No of Employees 95

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange PRTC (LON)

Revenue (2020) $17.4M 47.8% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX -1111.8% (2020 vs 2019)

Market Cap* $775.3M

Net Profit Margin (2020) XXX -784.8% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Puretech Health Plc

120+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Puretech Health Plc’s relevant decision makers and contact details.

90+

Catalyst Calendar

Proactively evaluate Puretech Health Plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

50+

Clinical Trials

Determine Puretech Health Plc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Puretech Health Plc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

7

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

5

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

17+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Puretech Health Plc’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Pipeline Programs:
LYT-100 - Inflammation and Fibrosis, Lymphedema and SARS-CoV-2
LYT-200 - Solid Tumors
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Others In July, the company purchased 86,484 shares.
2022 Others In July, the company purchased 140,304 shares.
2022 Others In June, the company purchased 3,432 own shares.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Puretech Health Plc Fortress Biotech Inc Five Prime Therapeutics Inc Alta Partners Verseon Corp
Headquarters United States of America United States of America United States of America United States of America United States of America
City Boston Bay Harbor Islands South San Francisco San Francisco Fremont
State/Province Massachusetts Florida California California California
No. of Employees 95 173 - - 33
Entity Type Public Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Christopher Viehbacher Chairman Executive Board - -
Daphne Zohar Founder; Director; Chief Executive Officer Executive Board - -
Bharatt Chowrira, Ph.D. Chief Business, Legal & Operating Officer; Director; President Executive Board 2021 -
George Farmer, Ph.D. Chief Financial Officer Senior Management 2021 -
Simona Levi, Ph.D. Corporate Secretary; Chief Legal Officer Senior Management 2021 -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer